RALEIGH and DURHAM, N.C., Aug. Nineteen (HSMN NewsFeed) — Smith & Nephew (NYSE: SNN ; LSE: SN ) Biologics & Spine is proceeding to the next stage in the approval process for the U.S. launch of DUROLANE(R) Single Injection, Stabilized Hyaluronic Acid. Repre…
Devices, Orthopaedic, FDA
Smith & Nephew, Q-Med, DUROLANE, Hyaluronic Acid

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Smith and Nephew Takes Single Injection PMA to Next Stage”
Leave a Comment